These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10993101)

  • 41. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Massive peritoneal fluid and markedly elevated serum CA125 and CA19-9 levels associated with an ovarian endometrioma.
    Park BJ; Kim TE; Kim YW
    J Obstet Gynaecol Res; 2009 Oct; 35(5):935-9. PubMed ID: 20149044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benign epithelial cyst of the spleen with a high production of carbohydrate antigen 19-9.
    Ishibashi R; Sakai T; Yamashita Y; Maekawa T; Hideshima T; Shirakusa T
    Int Surg; 1999; 84(2):151-4. PubMed ID: 10408287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study to evaluate the utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer.
    Gilani MM; Karimi Zarchi M; Ghaemmaghami F; Behtash N; Mousavi AS; Ansaripoor S
    Gynecol Oncol; 2007 Jun; 105(3):780-3. PubMed ID: 17433423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
    Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
    Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report.
    Kafali H; Artuc H; Demir N
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):85-8. PubMed ID: 15294374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis.
    Mabrouk M; Elmakky A; Caramelli E; Farina A; Mignemi G; Venturoli S; Villa G; Guerrini M; Manuzzi L; Montanari G; De Sanctis P; Valvassori L; Zucchini C; Seracchioli R
    Arch Gynecol Obstet; 2012 May; 285(5):1307-12. PubMed ID: 22065163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions.
    Somigliana E; Viganò P; Tirelli AS; Felicetta I; Torresani E; Vignali M; Di Blasio AM
    Hum Reprod; 2004 Aug; 19(8):1871-6. PubMed ID: 15218003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical usefulness of serum and immunohistochemical markers in patients with stage Ia and Ic ovarian cancer.
    Muramatsu T; Mukai M; Sato S; Tajima T; Nagase E; Ikeda M; Goya K; Shida M; Hirasawa T; Murakami M; Shinozuka T
    Oncol Rep; 2005 Oct; 14(4):861-5. PubMed ID: 16142343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
    Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
    Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
    J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased levels of both carbohydrate antigen 19-9 and duke pancreatic monoclonal antigen type 2 reflect postoperative prognosis in patients with pancreatic carcinoma.
    Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
    Pancreas; 2009 Aug; 38(6):619-24. PubMed ID: 19436235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis.
    Shen A; Xu S; Ma Y; Guo H; Li C; Yang C; Zou S
    J Int Med Res; 2015 Oct; 43(5):599-609. PubMed ID: 26246541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J; Sun X; Li B; Ming L
    Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
    Mann DV; Edwards R; Ho S; Lau WY; Glazer G
    Eur J Surg Oncol; 2000 Aug; 26(5):474-9. PubMed ID: 11016469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.